True Wealth Design’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$19.3K Sell
257
-62
-19% -$4.91K ﹤0.01% 844
2026
Q2
$25.2K Buy
319
+60
+23% +$5.1K 0.01% 731
2026
Q1
$22.3K Buy
259
+161
+164% +$14.5K 0.01% 672
2025
Q4
$8.56K Buy
98
+15
+18% +$1.14K ﹤0.01% 914
2025
Q3
$4.75K Buy
+83
New +$4.78K ﹤0.01% 1095
2025
Q2
– Sell
-8
Closed -$586 – 2674
2025
Q1
$586 Buy
+8
New +$661 ﹤0.01% 1485

Other funds holding GMED

True Wealth Design's GMED Position: Q3 2026 in Review

True Wealth Design reduced its Globus Medical (GMED) stake by 19% in Q3 2026, selling an estimated $4.91K and leaving 257 shares worth $19.3K. The position accounts for ﹤0.01% of the portfolio, ranked #844.

True Wealth Design first reported a position in GMED in Q1 2025 and has held it in 6 quarters since. The position peaked at $25.2K in Q2 2026. 55 funds tracked by Wall St. Rank hold GMED as of Q3 2026.

  • True Wealth Design held 257 shares of Globus Medical worth $19.3K as of Q3 2026.
  • True Wealth Design sold 62 Globus Medical shares in Q3 2026, an estimated $4.91K.
  • Globus Medical made up ﹤0.01% of True Wealth Design's portfolio in Q3 2026, its #844 holding.
  • True Wealth Design first reported a position in Globus Medical in Q1 2025 and has held it in 6 quarters since.
  • True Wealth Design's Globus Medical position peaked at $25.2K in Q2 2026.
  • 55 funds tracked by Wall St. Rank held Globus Medical as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.